Astrazeneca Pharma jumps 20% on delisting plan - The New Indian Express

Astrazeneca Pharma jumps 20% on delisting plan

Published: 03rd March 2014 01:19 PM

Last Updated: 03rd March 2014 01:19 PM

AstraZeneca Pharma India, an integrated biopharmaceutical company, jumped on Monday after the company said that its board will meet on Wednesday to discuss delisting proposal.

AstraZeneca Pharma India saidthatthe board has received a request from its promoter, AstraZeneca Pharmaceuticals AB (AZP AB) Sweden, to initiate a voluntary delisting process.Shares ofthe companyare trading at Rs 1,110.90, up Rs 185.15, or 20% at the Bombay Stock Exchange (BSE) on Monday at 12:05 p.m.The scrip has touched an intra-day high of Rs 1,110.90 and low of Rs 1,110.90. The total volume of shares traded at the BSE is 7,786.In the earlier session, the shares gained 9.51%, or Rs 80.4, at Rs 925.75. Currently, the stock is trading all time 52-week high, which is above 86.71% over the 52-week low of Rs 595.

comments powered by Disqus

Disclaimer: We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the NIE editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

Read More

follow us Mobile Site iPad News Hunt Android RSS Tumblr Linekin Pinterest Youtube Google Plus Twitter Facebook